Viral antigen‐specific CD8+ T‐cell responses are impaired in multiple myeloma

Multiple myeloma (MM) is associated with defects of humoral and cellular immunity, however, little is known about the frequency and function of antigen‐specific CD8+ T cells. Such information might be critical for the development of immunotherapy for MM patients. As a model, we assessed the frequenc...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2003-06, Vol.121 (6), p.842-848
Main Authors: Maecker, Britta, Anderson, Karen S., Von Bergwelt‐Baildon, Michael S., Weller, Edie, Vonderheide, Robert H., Richardson, Paul G., Schlossman, Robert L., Menezes, Isaura A., Xia, Zhinan, Munshi, Nikhil C., Anderson, Kenneth C., Nadler, Lee M., Schultze, Joachim L.
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Antigens, Viral - immunology
Biological and medical sciences
CD8 Antigens - immunology
Cell Transformation, Viral
Female
Herpesvirus 4, Human - immunology
Humans
Immunodeficiencies. Immunoglobulinopathies
Immunodominant Epitopes
Immunoglobulinopathies
Immunopathology
Influenza A virus - immunology
Male
Medical sciences
Middle Aged
multiple myeloma
Multiple Myeloma - immunology
T cells
T-Lymphocytes - immunology
tetramer
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiple myeloma (MM) is associated with defects of humoral and cellular immunity, however, little is known about the frequency and function of antigen‐specific CD8+ T cells. Such information might be critical for the development of immunotherapy for MM patients. As a model, we assessed the frequency and proliferation of CD8+ T cells specific for HLA‐A*0201‐restricted immunodominant epitopes from influenza A (Inf A) and Epstein–Barr virus (EBV). Experiments in identical twins demonstrated reduced numbers of antigen‐specific T cells after ex‐vivo antigenic challenge in the MM twin when compared with the healthy twin. Similarly, the proliferation and frequency of EBV‐ and Inf A‐specific T cells was also significantly reduced in a cohort of 24 previously untreated or conventionally treated MM patients when compared with 19 healthy individuals. In contrast, MM patients studied after receiving an autologous stem cell transplantation showed strikingly higher frequencies of EBV‐specific T cells with potential to proliferate ex vivo, suggesting that EBV‐specific T cells are readily expandable under these circumstances. These data identify an impaired response of CD8+ T cells in MM patients, which might in part explain the relatively limited success of anti‐MM immunisations. Prospective studies will determine whether such immune assessment strategies may identify patients more likely to benefit from cancer immunotherapy.
ISSN:0007-1048
1365-2141
DOI:10.1046/j.1365-2141.2003.04375.x